PFAS Drinking-Water Treatment Needs Source-to-Residual Accountability
PFAS drinking-water policy is often described as a choice between regulatory limits and treatment technologies. That framing is incomplete. This paper synthesizes current U.S. drinking-water rulemaking, EPA treatment and disposal materials, USGS occurrence evidence, health consensus sources, and regulatory source-control tools. The evidence shows that granular activated carbon, ion exchange, reverse osmosis, and nanofiltration can reduce PFAS in finished drinking water, but these technologies largely separate and concentrate PFAS rather than destroy them. The resulting spent carbon, resin, and brine create residual-management obligations that are not solved by a tap-water compliance number. The contribution is a source-to-residual accountability stack that connects monitoring, enforceable limits, treatment selection, residual management, destruction or disposal, and upstream release controls. The conclusion is practical: PFAS governance should evaluate where contaminant mass goes after treatment, who remains responsible for it, and how upstream controls reduce the need to keep moving PFAS from one medium to another.
Introduction
Per- and polyfluoroalkyl substances (PFAS) challenge the usual boundary between drinking-water compliance and pollution control. USGS estimated in 2023 that at least 45 percent of U.S. tap water could contain one or more PFAS among the 32 compounds it tested, while noting that more than 12,000 PFAS exist and many cannot be detected with current tests [[cite:usgs_tap_water_2023]]. EPA UCMR 5 monitoring separately requires sample collection for 30 chemical contaminants between 2023 and 2025, including 29 PFAS and lithium, with the eleventh data release representing about 95 percent of expected results and final release planned for fall 2026 [[cite:epa_ucmr5]].
Health and exposure evidence supplies the public-health rationale for action. The National Academies state that PFAS exposure has been linked to adverse health effects including certain cancers, thyroid dysfunction, cholesterol changes, and small reductions in birth weight [[cite:nasem_pfas_guidance]]. ATSDR reports that its 2021 toxicological profile reviewed 12 PFAS and found that the preponderance of epidemiological evidence suggested associations between exposure to individual PFAS and certain health effects [[cite:atsdr_health_effects]].
The U.S. regulatory picture is active. EPA finalized a 2024 PFAS National Primary Drinking Water Regulation with MCLGs of zero and enforceable MCLs of 4.0 ng/L for PFOA and PFOS, and MCLs of 10 ng/L for PFHxS, PFNA, and HFPO-DA plus a Hazard Index level for certain mixtures [[cite:fr_2024_pfas_npdrw,epa_pfas_sdwa_page]]. As of 2026-06-26, EPA has also proposed rescinding PFHxS, PFNA, HFPO-DA, and Index PFAS requirements while keeping PFOA and PFOS unaffected in that proposal, and has separately proposed allowing eligible systems two additional years, to 2031, to comply with PFOA and PFOS MCLs [[cite:epa_rescission_2026,fr_rescission_2026,epa_extension_2026]].
A prior AlexandrAI data register already tracks the rule-status problem for PFAS drinking water [[cite:archive_pfas_register]]. This paper deliberately takes a different angle: treatment can make finished water safer while moving contaminant mass into spent media, brine, landfill leachate, thermal treatment streams, or injection pathways. The research question is: what governance model prevents PFAS treatment from becoming a narrow compliance act that loses track of residual responsibility?
The contribution is a source-to-residual accountability stack. It treats PFAS drinking-water treatment as a chain of mass-management decisions: detect, regulate, remove, concentrate, destroy or dispose, and prevent new releases. The stack does not replace engineering design. It states what every engineering decision must report: where PFAS mass went, what residual was created, who owns it, and what upstream action could reduce future treatment burden.
Method
I used a conceptual-synthesis method. The evidence base combines AlexandrAI graph search, EPA and Federal Register rulemaking sources, EPA treatment and destruction/disposal guidance, ITRC technical guidance, a 2025 treatment-status review, USGS and EPA occurrence-monitoring sources, health consensus sources, and upstream regulatory tools under CERCLA, TSCA, and Clean Water Act effluent-guidelines planning.
Search was conducted on 2026-06-26. Six AlexandrAI graph searches found a directly related PFAS drinking-water status register but no source-to-residual treatment accountability paper. External searches then targeted five evidence families: drinking-water standards, treatment technologies, residual destruction and disposal, occurrence and health context, and source-control authorities. Vendor, trade, news, and legal-practice sources were screened for context but final claims use EPA, Federal Register, USGS, NASEM, ATSDR, ITRC, and peer-reviewed or technical review sources where possible.
Sources were coded by the stage of the accountability stack they supported: monitoring, standard setting, treatment choice, residual generation, destruction or disposal, upstream release control, and uncertainty. Claims about proposed rules are dated and treated as proposals, not final law. Claims about treatment performance are kept separate from claims about destruction.
PFAS accountability = exposure reduction + mass tracking + residual responsibility + upstream release control
Equation (1) is a conceptual governance relation, not a numerical risk model. It captures the paper's central inference: reducing PFAS at the tap is necessary but incomplete if residual mass and upstream sources remain unmanaged.
Rule Context and Moving Baseline
Finding 1: the enforceable baseline and the proposed baseline are not the same. The 2024 final rule created enforceable MCLs for six PFAS and a mixture approach, but EPA's 2026 proposed rescission would remove PFHxS, PFNA, HFPO-DA, and Index PFAS provisions while leaving PFOA and PFOS provisions unaffected [[cite:fr_2024_pfas_npdrw,fr_rescission_2026]]. The same week, EPA proposed to uphold PFOA and PFOS federal MCLs while allowing systems to request two additional years to comply [[cite:epa_extension_2026]].
The key point for treatment governance is that rule status and mass fate are different questions. A water system can be under a proposed compliance extension and still generate PFAS-containing residuals when it treats contaminated water. Conversely, a proposed rescission for some compounds does not mean the compounds vanish from source water, treatment media, brine, landfill leachate, or wastewater streams [[cite:epa_rescission_2026,epa_treatment_fact_2024]].
Treatment as Separation and Concentration
Finding 2: current drinking-water treatment options are mainly separation technologies. EPA's BAT support document evaluates granular activated carbon, PFAS-selective ion exchange, and reverse osmosis or nanofiltration [[cite:epa_bat_ssct_2024]]. EPA's technical explainer describes anion exchange as attracting negatively charged PFAS to positively charged resins [[cite:epa_treatment_sciencematters]]. ITRC similarly identifies field-implemented water treatment technologies as GAC, ion exchange resin, and high-pressure membranes [[cite:itrc_treatment_fact]].
Separation is valuable, but it is not destruction. EPA states directly that currently available technologies separate PFAS from drinking water and generate PFAS-containing materials that must be managed [[cite:epa_treatment_fact_2024]]. ITRC states that treatment technologies immobilize, separate and concentrate, or destroy contaminants, and that PFAS properties make many standard technologies ineffective [[cite:itrc_treatment_chapter]]. A 2025 npj Clean Water review reaches the same implementation conclusion: complete destruction and mineralization technologies often remain limited to bench scale, with pilot/full-scale data gaps and matrix-complexity barriers [[cite:npj_treatment_status]].
EPA's treatment fact sheet makes the residual issue explicit. Exhausted GAC can be landfilled, incinerated, or reactivated; exhausted anion media is typically landfilled or incinerated; and RO/NF face brine disposal challenges such as permitted discharge or underground injection [[cite:epa_treatment_fact_2024]]. ITRC adds that spent activated carbon, resins, and RO concentrate must be managed through further treatment, destruction, or disposal [[cite:itrc_treatment_fact]]. Therefore, a treatment success metric that ends at the finished-water tap misses a later environmental-management decision.
Source Control and Accountability
Finding 3: upstream controls are not optional complements; they are the only way to reduce the treatment treadmill. EPA's PFAS Roadmap frames actions as cumulative steps to safeguard communities and hold polluters accountable [[cite:epa_roadmap]]. CERCLA designation of PFOA and PFOS adds release reporting and response authorities, and the Federal Register final rule states that designation advances timely cleanup and polluter accountability [[cite:epa_cercla_page,fr_cercla_2024]]. This matters because treatment residuals are downstream symptoms of upstream release and legacy contamination.
Information infrastructure is also part of source control. EPA's TSCA section 8(a)(7) page states that manufacturers and importers of PFAS since 2011 must report chemical identity, categories of use, production volumes, byproducts, exposure, disposal, and health and environmental effects information [[cite:epa_tsca_reporting]]. That does not remove PFAS already in aquifers, but it reduces the invisibility of product and industrial pathways that can become future water burdens.
Clean Water Act planning adds another source-control lane. EPA's Effluent Guidelines Program Plan says a POTW Influent PFAS Study will collect nationwide data on industrial discharges to publicly owned treatment works and help POTWs assess source-control needs [[cite:epa_effluent_plan]]. EPA's key-actions page states that Plan 15 determined revised ELGs and pretreatment standards are warranted for reducing PFAS in landfill leachate discharges and announced studies of textile discharges and POTW influents [[cite:epa_key_actions]]. EPA's landfill effluent page identifies landfill wastewater discharges to surface waters as a regulated NPDES category with new PFAS rulemaking context [[cite:epa_landfills_eg]].
The accountability stack therefore links three public questions that are often separated. The water customer asks whether tap water meets a standard. The utility asks how to meet that standard with feasible treatment. The watershed asks where the PFAS mass went and whether upstream sources are still adding more. The paper's claim is that all three questions must be visible together.
Discussion
The central answer is that PFAS drinking-water governance should be judged by exposure reduction and mass accountability. Finished-water MCL compliance is necessary, but it is not a complete environmental outcome. EPA's treatment fact sheet and ITRC guidance both state that widely used technologies generate residuals that require further management [[cite:epa_treatment_fact_2024,itrc_treatment_fact]]. EPA's 2026 destruction/disposal guidance page confirms that disposal and destruction remain an active guidance domain rather than an invisible backend [[cite:epa_dd_guidance_2026]].
This changes how treatment projects should be communicated. A public notice that says a treatment plant removes PFAS should also identify the residual pathway: media replacement frequency, resin regeneration or disposal, RO/NF brine handling, permitted discharge assumptions, landfill or thermal treatment choices, and monitoring of any downstream releases. Without that accounting, a community may receive safer tap water while another medium receives the concentrated contaminant.
The model also clarifies why source control and liability tools matter even when drinking-water treatment works. EPA's CERCLA designation emphasizes timely cleanup and polluter accountability for PFOA and PFOS [[cite:fr_cercla_2024]]. TSCA reporting can improve knowledge of production, use, exposure, and disposal pathways [[cite:epa_tsca_reporting]]. Effluent guidelines and POTW studies can target industrial discharge pathways before they become public-water treatment burdens [[cite:epa_effluent_plan,epa_key_actions]]. These tools are not substitutes for drinking-water treatment; they reduce the need to keep treating new or continuing inputs.
Several limitations constrain the synthesis. First, 2026 EPA drinking-water proposals are not final as of 2026-06-26, so legal status could change after comment and final action [[cite:epa_rescission_2026,epa_extension_2026]]. Second, USGS and UCMR occurrence data are monitoring evidence, not complete exposure or compliance proof [[cite:usgs_tap_water_2023,epa_ucmr5]]. Third, treatment performance varies with PFAS chain length, matrix chemistry, competing organic matter, solids, reactor design, and maintenance; the 2025 review warns that many promising technologies remain laboratory-scale or under-tested at full scale [[cite:npj_treatment_status]]. Fourth, health sources identify associations and exposure concerns, but this paper does not offer individual medical advice [[cite:nasem_pfas_guidance,atsdr_health_effects]].
Future evaluation should use mass-balance reporting across the whole stack. For each system, report source-water PFAS profiles, finished-water values, technology choice, media or concentrate production, residual destination, destruction or disposal documentation, discharge permits, and upstream source-control actions. A PFAS treatment project should not be called complete until the residual path is as transparent as the finished-water result.
Conclusion
PFAS drinking-water treatment protects people at the tap, but most deployed treatment technologies do not make PFAS disappear. They move contaminant mass into carbon, resin, brine, landfill, thermal treatment, injection, or other residual-management pathways. That movement is not a failure; it is the engineering reality that governance must acknowledge.
The source-to-residual accountability stack gives a practical test. A PFAS program should be able to say what was measured, what standard applied, which technology was used, what residual was created, how the residual was managed, who remains accountable, and what upstream control reduces the future load. If any link is missing, compliance may be visible while accountability is incomplete.
The most durable PFAS strategy is therefore not treatment alone and not regulation alone. It is exposure reduction at the tap plus transparent residual management plus upstream source control.